Opportunity
DIBBS #SPE2DP-26-T-3116
DLA Solicitation for Bupropion Hydrochloride Sustained Release Tablets, 150 mg
Posted
April 28, 2026
Respond By
May 04, 2026
Identifier
SPE2DP-26-T-3116
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is soliciting bids for Bupropion Hydrochloride Sustained Release Tablets, 150 mg, 60 tablets per bottle, under NSN 6505-01-498-3167. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs and Vendors: - Cardinal Health, Inc. - AmerisourceBergen Drug Corp - Sciegen Pharmaceuticals Inc - Radha Pharmaceuticals Inc - Products Requested: - Bupropion Hydrochloride Sustained Release Tablets, 150 mg, 60 tablets per bottle - NSN: 6505-01-498-3167 - Quantity: 1 unit - Approved part numbers: NDC00185-0415-60, NDC00173-0135-55, NDC00591-3541-60, NDC50228-0175-60, NDC77771-0175-60 - Unique or Notable Requirements: - Delivery required within 20 days FOB destination to Fort Bragg, NC - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Compliance with DFARS and FAR clauses, including cybersecurity and hazardous material handling - FDA regulated drug - Place of Performance/Delivery: - Fort Bragg, NC (2530 Taylor Street, Bldg 2530, 28310) - DLA contracting office in Philadelphia, PA
Description
BUPROPION HYDROCHLO (QTY: 1, NSN: 6505-01-498-3167, Purchase Request: 7016505449) Approved Sources: - CAGE: 00E55, Part No: NDC00185-0415-60, Company: CARDINAL HEALTH, INC. - CAGE: 1XUY5, Part No: NDC00173-0135-55, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 1XUY5, Part No: NDC00185-0415-60, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 1XUY5, Part No: NDC00591-3541-60, Company: AMERISOURCEBERGEN DRUG CORP - CAGE: 34006, Part No: NDC00173-0135-55 - CAGE: 8NLP1, Part No: NDC50228-0175-60, Company: SCIEGEN PHARMACEUTICALS INC - CAGE: 8PNH3, Part No: NDC77771-0175-60, Company: RADHA PHARMACEUTICALS INC